Steven Ramael

2.7k total citations
40 papers, 2.1k citations indexed

About

Steven Ramael is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Steven Ramael has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pharmacology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Steven Ramael's work include Hypothalamic control of reproductive hormones (7 papers), Estrogen and related hormone effects (7 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Steven Ramael is often cited by papers focused on Hypothalamic control of reproductive hormones (7 papers), Estrogen and related hormone effects (7 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Steven Ramael collaborates with scholars based in United States, Belgium and Germany. Steven Ramael's co-authors include Thijs van Iersel, Natalie Houwing, Viktoria Moschetti, Stephan Glund, Paul Reilly, Joachim Stangier, Benjamin Lang, Michael Schmohl, Graeme L. Fraser and Stephen H. Norris and has published in prestigious journals such as The Lancet, Circulation and The Journal of Immunology.

In The Last Decade

Steven Ramael

39 papers receiving 2.0k citations

Peers

Countries citing papers authored by Steven Ramael

Since Specialization

Citations

This map shows the geographic impact of Steven Ramael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Ramael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Ramael more than expected).

Fields of papers citing papers by Steven Ramael

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Ramael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Ramael. The network helps show where Steven Ramael may publish in the future.

Co-authorship network of co-authors of Steven Ramael

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Ramael. A scholar is included among the top collaborators of Steven Ramael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Ramael. Steven Ramael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause 2020 ·Menopause The Journal of The North American Menopause Society ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Robin Kroll, Nanette Santoro, Misun Lee, Laurence Skillern, Steven Ramael	75
2	OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study 2019 ·Journal of the Endocrine Society ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Misun Lee, Laurence Skillern, Steven Ramael	3
3	Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men 2018 ·Clinical Drug Investigation ·Ka Lai Yee, Jacqueline B. McCrea, Deborah Panebianco, Wen Liu, Nicole Lewis, Tamara D. Cabalu, Steven Ramael, Rebecca E. Wrishko	21
4	Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials 2018 ·Rheumatology and Therapy ·Steven Ramael, (unknown), Renger G. Tiessen, Thijs van Iersel, Viktoria Moschetti, Benjamin Lang, Ivo Sonderegger, Sabrina Wiebe, Bernd Liedert, (unknown)	14
5	Clinical evaluation of the NK3 receptor antagonist fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flashes 2017 ·Maturitas ·Herman Depypere, D. Timmerman, Gilbert Donders, (unknown), Steven Ramael, Jean Combalbert, Hamid R. Hoveyda, Graeme L. Fraser	11
6	First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28 2016 ·The Journal of Immunology ·Nicolas Poirier, Gilles Blancho, (unknown), Caroline Mary, Tim Van Assche, (unknown), Steven Ramael, Weirong Wang, Virginie Thépenier, Cécile Braudeau, Nina Salabert, Régis Josien, I.E. Anderson, Ian Gourley, Jean‐Paul Soulillou, (unknown), Bernard Vanhove	47
7	Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors 2016 ·Alzheimer s Research & Therapy ·Bianca Van Broeck, Maarten Timmers, Steven Ramael, Jennifer Bogert, Leslie M. Shaw, Marc Mercken, (unknown), Luc Van Nueten, Sebastiaan Engelborghs, Johannes Streffer	10
8	Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteers 2016 ·Thrombosis and Haemostasis ·Michael Schmohl, Stephan Glund, Akiko Harada, (unknown), Marina De Smet, Viktoria Moschetti, Steven Ramael, Ippei Ikushima, (unknown), Paul Reilly, Joachim Stangier	23
9	A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran 2015 ·Thrombosis and Haemostasis ·Viktoria Moschetti, Stephen H. Norris, Joachim Stangier, Michael Schmohl, Joanne van Ryn, Benjamin Lang, Steven Ramael, Paul Reilly, Stephan Glund	183
10	Effect of fermented milk containing Lactobacillus casei strain Shirota on constipation-related symptoms and haemorrhoids in women during puerperium 2014 ·Beneficial Microbes ·Tatsuo Sakai, Hiroyuki Kubota, (unknown), Lien Gheyle, Steven Ramael, K Oishi	19
11	Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers 2013 ·Circulation ·Stephan Glund, Joachim Stangier, Michael Schmohl, Marina De Smet, Dietmar Ganßer, Benjamin Lang, Viktoria Moschetti, Steven Ramael, Paul Reilly	41
12	Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex 2011 ·Clinical Drug Investigation ·Pieter‐Jan de Kam, Martijn P. van den Heuvel, Peter Grobara, Alex Zwiers, (unknown), (unknown), Steven Ramael, Pierre Peeters	9
13	Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals 2011 ·European Journal of Endocrinology ·Eunkyung Kauh, Lori Mixson, Marie‐Pierre Malice, (unknown), Steven Ramael, (unknown), Tom Reynders, Kristien Van Dyck, Chan Beals, Elizabeth Rosenberg, Marcella Ruddy	46
14	Systemic Exposure and Implications for Lung Deposition with an Extra-Fine Hydrofluoroalkane Beclometasone Dipropionate/Formoterol Fixed Combination 2009 ·Clinical Pharmacokinetics ·Jean Bousquet, Gianluigi Poli, Daniela Acerbi, Raffaella Monno, Steven Ramael, (unknown)	22
15	Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects 2007 ·Clinical Pharmacology & Therapeutics ·Marian Iwamoto, (unknown), (unknown), Martine E. Laethem, M. De Smet, (unknown), (unknown), (unknown), Steven Ramael, (unknown), JA Stone, (unknown), JA Wagner	134
16	Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study 2006 ·Epilepsia ·Steven Ramael, (unknown), Christian Otoul, Nathalie Toublanc, (unknown), Zhihong Lu, Armel Stockis	149
17	Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects 2006 ·Clinical Therapeutics ·Steven Ramael, Florimond De Smedt, Nathalie Toublanc, Christian Otoul, Pierre Boulanger, (unknown), Armel Stockis	88
18	Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers 2006 ·Clinical Therapeutics ·Arthur Bergman, (unknown), Yanyan Zhou, Bingming Yi, Martine E. Laethem, Marina De Smet, Karen Snyder, Deborah Hilliard, Wesley Tanaka, Wei Zeng, Michael Tanen, Amy Q. Wang, Li Chen, Gregory A. Winchell, Michael J. Davies, Steven Ramael, John A. Wagner, Gary Herman	220
19	First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide 2005 ·Anesthesiology ·(unknown), Steven Ramael, Natalie Houwing, Thijs van Iersel	227
20	Steady‐State Pharmacokinetics of Galantamine Are Not Affected by Addition of Memantine in Healthy Subjects 2005 ·The Journal of Clinical Pharmacology ·Caiping Yao, (unknown), Michael Gold, Jeffrey S. Nye, Steven Ramael, (unknown), (unknown), Tom Verhaeghe, Qinying Zhao	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact